aspartic acid
UkraineDrugs containing this active substance
-
The drug is used for parenteral (intravenous) nutrition when a patient cannot receive sufficient nutrients orally or through the intestines. It provides the body with amino acids necessary for protein synthesis and electrolytes.
Form: solution for infusion
Active substance Dosage isoleucine 8.9 g/L leucine 5 g/L lysine 6.85 g/L methionine 4.4 g/L phenylalanine 4.7 g/l threonine 4.2 g/L tryptophan 1.6 g/L valine 6.2 g/L arginine 11.5 g/L histidine 3 g/L alanine 10.5 g/L glycine 12 g/L aspartic acid 5.6 g/L glutamic acid 7.2 g/L proline 5.5 g/l serine 2.3 g/L tyrosine 0.4 g/L sodium acetate 2.858 g/L sodium hydroxide 0.36 g/l potassium acetate 2.453 g/L magnesium chloride 0.508 g/L sodium phosphate dibasic 3.581 g/L ATC: B05BA01
Manufacturer: B. Braun Melsungen AG (manufacturing, primary and secondary packaging, batch release, batch control)
-
The drug is used to provide the body with amino acids during parenteral nutrition for patients with severe hepatic insufficiency, as well as for the prevention and treatment of hepatic encephalopathy.
Form: solution for infusion
Active substance Dosage isoleucine 8.8 g/L leucine 13.6 g/L lysine 7.51 g/L methionine 1.2 g/L phenylalanine 1.6 g/L threonine 4.6 g/l tryptophan 1.5 g/l valine 10.6 g/L arginine 8.8 g/L histidine 4.7 g/l glycine 6.3 g/l alanine 8.3 g/L proline 7.1 g/L aspartic acid 2.5 g/l asparagine 0.48 g/L cysteine 0.59 g/L glutamic acid 5.7 g/L ornithine 1.3 g/L serine 3.7 g/l tyrosine 0.7 g/l ATC: B05BA01
-
The drug is used for the symptomatic treatment of hepatic encephalopathy (in both latent and overt forms).
Form: concentrate for infusion solution
Active substance Dosage ornithine 5 g/10 ml aspartic acid 5 g/10 ml ATC: A05BA
Manufacturer: Merck Pharma GmbH & Co. KGaA (quality control testing and batch release)
-
The drug is used to treat complications caused by impaired detoxification function of the liver (e.g., in liver cirrhosis) accompanied by symptoms of hepatic encephalopathy.
Form: granules
Active substance Dosage ornithine 3 g aspartic acid 0 ATC: A05BA
-
The drug is used for the symptomatic treatment of latent and overt hepatic encephalopathy.
Form: concentrate for infusion solution
Active substance Dosage ornithine 500 mg/ml aspartic acid 500 mg/ml ATC: A05BA
Manufacturer: Farmex Group LLC
-
The drug is used to treat complications caused by impaired detoxification function of the liver (e.g., in liver cirrhosis) if accompanied by symptoms of hepatic encephalopathy.
Form: granules
Active substance Dosage ornithine 3 g aspartic acid 0 ATC: A05BA
Manufacturer: Farmex Group LLC (batch release)
-
The drug is used to treat complications caused by impaired detoxification function of the liver (e.g., in cirrhosis), especially if there are symptoms of hepatic encephalopathy, including impaired consciousness (precoma, coma).
Form: concentrate for infusion solution
Active substance Dosage ornithine 500 mg/ml aspartic acid 500 mg/ml ATC: A05BA
Manufacturer: Farmak JSC
-
The drug is used to treat complications arising from impaired detoxification function of the liver (e.g., in liver cirrhosis) with symptoms of hepatic encephalopathy.
Form: granules for oral solution
Active substance Dosage ornithine 3 g aspartic acid 0 ATC: A05BA
Manufacturer: Farmak JSC
-
The drug is used for parenteral (intravenous) nutrition of patients with moderate to severe catabolism if they cannot receive sufficient nutrients orally or via the intestine. It provides the body with energy, amino acids, fatty acids, glucose, and electrolytes.
Form: emulsion, for infusion
Active substance Dosage glucose 144 g/l soybean oil 20 g/L medium chain triglycerides 20 g/L isoleucine 3.284 g/l leucine 4.384 g/L lysine 3.186 g/l methionine 2.736 g/L phenylalanine 4.916 g/L threonine 2.54 g/L tryptophan 0.8 g/l valine 3.604 g/l arginine 3.78 g/l histidine 1.753 g/L alanine 6.792 g/l aspartic acid 2.1 g/L glutamic acid 4.908 g/L glycine 2.312 g/L proline 4.76 g/L serine 4.2 g/L ATC: B05BA10
Manufacturer: B. Braun Melsungen AG